Table 2.
Liver disease assessment for each patient: Number/size of focal lesions, scoring, and PT-INR of each HCC patient according to the Milan criteria
| Patients | Number of focal lesions | Size of focal lesions | MELDa Score | Child-Pugh Score | PT-INRb |
|---|---|---|---|---|---|
| Patient 1 | 3 focal lesions | 1.5 cm, 1 cm, and 1 cm | 11 | C | 1.4 |
| Patient 2 | Unifocal | 2.5 cm | 15 | C10 | 1.6 |
| Patient 3 | 3 focal lesions | 2 cm, 2.5 cm, and 3 cm | 10 | C11 | 2.4 |
| Patient 4 | 3 focal lesions | 2 cm, 2 cm, and 3.5 cm | 10 | C | 2 |
| Patient 5 | Unifocal | 1.5 × 2 cm | 16 | C | 1.4 |
| Patient 6 | 3 focal lesions | 3 × 4 cm, 1 cm, and 1 cm | 12 | B | 1.5 |
| Patient 7 | Unifocal | 4 cm | 11 | B7 | 1.5 |
| Patient 8 | 3 focal lesions | 4 cm, 1 cm, and 1 cm | 8 | A5 | 1.3 |
| Patient 9 | 3 focal lesions | 1 cm, 1 cm, and 1.5 cm | 17 | C | 1.5 |
| Patient 10 | Unifocal | 2.5 cm | 10 | B8 | 1.4 |
| Patient 11 | 2 focal lesions | 1 cm and 1.7 cm | 15 | B8 | 1.4 |
| Patient 12 | 3 focal lesions | 1 cm each | 17 | C11 | 1.8 |
| Patient 13 | Unifocal | 3 cm | 13 | B7 | 1.6 |
| Patient 14 | 3 focal lesions | 3 cm, 1.5 cm, and 2 cm | 15 | B | 1.6 |
| Patient 15 | 3 focal lesions | 1 cm, 1 cm, and 4 cm | 12 | B7 | 1.14 |
| Patient 16 | 2 focal lesions | 3 cm and 1.5 cm | 19 | C12 | 1.9 |
| Patient 17 | 2 focal lesions | 1.5 cm and 3 cm | 16 | C10 | 1.55 |
| Patient 18 | 3 focal lesions | 2.5 cm, 2.5 cm, 1.5 cm | 9 | B7 | 1.18 |
| Patient 19 | 3 focal lesions | 1.5 cm, 1 cm, and 1 cm | 11 | B8 | 1.19 |
| Patient 20 | Unifocal | 2 cm | 18 | C | 1.7 |
| Patient 21 | Unifocal | 1.5 cm | 17 | C | 1.55 |
| Patient 22 | 3 focal lesions | 3 cm, 2.5 cm, and 1 cm | 12 | B | 1.6 |
a MELD: Model for End-stage Liver Disease score
b PT-INR: international normalized ratio for prothrombin time